Index

e-ISSN 1828-1427

  

Rivista trimestrale di Sanità Pubblica Veterinaria edita dall'Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise ‘G. Caporale’

A quarterly journal devoted to veterinary public health, veterinary science and medicine published by the Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise ‘G. Caporale’ in Teramo, Italy

Editorial policy
Copyright and disclaimers
Guidelines for Authors
Editors
Honorary Members
Editorial Board
Scientific Advisory Board
Associate Editors
Issues online
Tariffs
Contact
 

ISSUES ONLINE

2013 - Volume 49 (1), January-March
   
 
Rossella Lelli, Umberto Molini, Gaetano Federico Ronchi, Emanuela Rossi, Paola Franchi, Simonetta Ulisse, Gisella Armillotta, Sara Capista, Siegfried Khaiseb, Mauro Di Ventura & Attilio Pini  
Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy
in horses and guinea-pig model		 89-98
       
Summary
African horse sickness (AHS) is a non-contagious viral disease of solipeds transmitted by Culicoides. The disease is endemic in most African countries. Past experience has shown that Italy is a country exposed to emerging infectious diseases endemic to Africa; an incursion of AHS virus together with the widespread presence of Culicoides vectors could be the cause of a serious epidemic emergency. A live attenuated vaccine containing seven of the nine viral serotypes, serotype 5 and 9 are excluded, is commercially available from Onderstepoort Biological Products. However, the use of live vaccines is a matter of endless disputes, and therefore inactivated or recombinant alternative products have been investigated over the years. Since research on AHS is hampered by the use of horses to evaluate vaccine potency, in a previous experiment serological response to serotypes 5 and 9 was assayed in guinea-pigs and horses. A durable and comparable serological response was observed in the two animal species. In the present study antibody response in horses and guinea-pigs, immunised with the inactivated-adjuvanted vaccine formulated with serotype 9, was tested over a period of 12 months. When immunity was challenged, horses were protected from infection and disease. Antibody response in horses and guinea-pigs compared favourably.

Keywords
African horse sickness, Antibody response, Challenge, Guinea-pig, Inactivated vaccine, Namibia, Serotype 9.


Full article

      
 
    © Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise 2013